The role of chemotherapy in osteogenic sarcoma
- 31 August 1995
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 20 (1-2) , 61-85
- https://doi.org/10.1016/1040-8428(94)00145-j
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patientsEuropean Journal Of Cancer, 1994
- Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patientsEuropean Journal Of Cancer, 1993
- Correlations between margins and local recurrence rate in surgery for osteosarcomas (OS)European Journal Of Cancer, 1993
- Limb salvage in fractured bone sarcomasEuropean Journal Of Cancer, 1993
- Heart and lungfunction in patients with pulmonary metastases of osteosarcoma treated with metastatectomy and 20 gy postoperative irradiationEuropean Journal Of Cancer, 1993
- Inhibition of Metastatic Behavior of Murine Osteosarcoma by HypophysectomyJNCI Journal of the National Cancer Institute, 1992
- Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experienceCancer, 1992
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985